CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: chemosterilant
Accession: CHEBI:23092
browse the term
Definition: A substance intended to sterilize any organism.
Synonyms: related_synonym: chemosterilants
xref: Wikipedia:Chemosterilant
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Adrb2
adrenoceptor beta 2
decreases response to substance
ISO
ADRB2 protein results in decreased susceptibility to Busulfan
CTD
PMID:7202579
NCBI chr18:57,912,760...57,914,802
Ensembl chr18:55,502,903...55,644,512
G
Ahr
aryl hydrocarbon receptor
increases expression
ISO
Busulfan results in increased expression of AHR mRNA
CTD
PMID:35641671
NCBI chr 6:57,961,423...57,998,901
Ensembl chr 6:52,234,089...52,271,568
G
Anp32b
acidic nuclear phosphoprotein 32 family member B
multiple interactions
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of ANP32B protein
CTD
PMID:20933509
NCBI chr 5:65,538,872...65,561,305
Ensembl chr 5:60,743,443...60,765,717
G
Apex1
apurinic/apyrimidinic endodeoxyribonuclease 1
increases response to substance
ISO
APEX1 protein mutant form results in increased susceptibility to Busulfan
CTD
PMID:19470598
NCBI chr15:26,618,146...26,620,330
Ensembl chr15:24,144,362...24,146,785
G
Ar
androgen receptor
multiple interactions
ISO
Busulfan inhibits the reaction [Metribolone results in increased activity of AR protein]
CTD
PMID:18324785
NCBI chr X:67,135,317...67,304,476
Ensembl chr X:63,104,771...63,273,925
G
Arhgdia
Rho GDP dissociation inhibitor alpha
multiple interactions affects response to substance
ISO
ARHGDIA mRNA affects the reaction [Busulfan results in increased activity of CASP3 protein] ARHGDIA mRNA affects the susceptibility to Busulfan
CTD
PMID:17264767
NCBI chr10:106,352,858...106,356,347
Ensembl chr10:105,854,533...105,858,023
G
Atf4
activating transcription factor 4
increases expression multiple interactions
ISO
Busulfan results in increased expression of ATF4 mRNA 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of ATF4 protein]
CTD
PMID:35533795 PMID:35641671
NCBI chr 7:113,684,681...113,686,739
Ensembl chr 7:111,804,183...111,806,446
G
Atm
ATM serine/threonine kinase
multiple interactions
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of ATM protein
CTD
PMID:20933509
NCBI chr 8:62,724,939...62,829,040
Ensembl chr 8:53,831,093...53,932,437
G
Becn1
beclin 1
increases expression multiple interactions
ISO
Busulfan results in increased expression of BECN1 protein 3-methyladenine inhibits the reaction [Busulfan results in increased expression of BECN1 protein]
CTD
PMID:38220133
NCBI chr10:86,731,649...86,747,002
Ensembl chr10:86,231,388...86,246,742
G
Bmp4
bone morphogenetic protein 4
decreases expression
EXP
Busulfan results in decreased expression of BMP4 mRNA
CTD
PMID:15786497
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:19,618,542...19,623,306
G
Casp3
caspase 3
multiple interactions increases activity
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP3 protein; [decitabine co-treated with Busulfan] results in increased activity of CASP3 protein; ARHGDIA mRNA affects the reaction [Busulfan results in increased activity of CASP3 protein]
CTD
PMID:17264767 PMID:18339423 PMID:19732952 PMID:20933509
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp8
caspase 8
increases activity multiple interactions
ISO
Busulfan results in increased activity of CASP8 protein [decitabine co-treated with Busulfan] results in increased activity of CASP8 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP8 protein]
CTD
PMID:18339423 PMID:19732952
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of CASP9 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased activity of CASP9 protein]
CTD
PMID:19732952 PMID:20933509
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
decreases expression
ISO
Busulfan results in decreased expression of CAT protein
CTD
PMID:38123000
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cdc25b
cell division cycle 25B
multiple interactions
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CDC25B protein
CTD
PMID:20933509
NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:118,407,128...118,417,272
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Busulfan results in decreased expression of CDK2 mRNA
CTD
PMID:15388331
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,129,811...1,137,403
G
Cdk4
cyclin-dependent kinase 4
decreases expression
ISO
Busulfan results in decreased expression of CDK4 mRNA
CTD
PMID:15388331
NCBI chr 7:64,771,453...64,774,891
Ensembl chr 7:62,883,105...62,942,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO
Busulfan results in increased expression of CDKN1A protein [clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased expression of CDKN1A protein
CTD
PMID:16882877 PMID:20933509
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
increases expression
ISO
Busulfan results in increased expression of CDKN2A mRNA
CTD
PMID:14500376
NCBI chr 5:109,100,763...109,114,448
Ensembl chr 5:103,984,949...104,003,149
G
Chek1
checkpoint kinase 1
multiple interactions
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CHEK1 protein
CTD
PMID:20933509
NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:36,420,569...36,441,009
G
Chek2
checkpoint kinase 2
multiple interactions
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of CHEK2 protein
CTD
PMID:20933509
NCBI chr12:51,448,838...51,481,159
Ensembl chr12:45,788,827...45,821,286
G
Cldn11
claudin 11
multiple interactions decreases expression
ISO
4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of CLDN11 protein] Busulfan results in decreased expression of CLDN11 mRNA; Busulfan results in decreased expression of CLDN11 protein
CTD
PMID:35533795
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
G
Col1a1
collagen type I alpha 1 chain
increases expression
ISO
Busulfan results in increased expression of COL1A1 mRNA
CTD
PMID:37597760
NCBI chr10:80,380,458...80,397,461
Ensembl chr10:79,883,622...79,900,624
G
Col3a1
collagen type III alpha 1 chain
increases expression
ISO
Busulfan results in increased expression of COL3A1 mRNA
CTD
PMID:37597760
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:47,374,593...47,410,547
G
Col4a1
collagen type IV alpha 1 chain
affects expression
ISO
Busulfan affects the expression of COL4A1 mRNA
CTD
PMID:15941629
NCBI chr16:84,885,597...84,996,482
Ensembl chr16:78,183,533...78,294,412
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases activity
ISO
Busulfan results in decreased activity of CYP1A1 protein
CTD
PMID:33814510
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of DDIT3 protein]
CTD
PMID:35533795
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
increases phosphorylation multiple interactions
ISO
Busulfan results in increased phosphorylation of EIF2AK3 protein 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased phosphorylation of EIF2AK3 protein]
CTD
PMID:35533795
NCBI chr 4:104,363,838...104,425,271
Ensembl chr 4:102,805,510...102,866,911
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
increases phosphorylation multiple interactions
ISO
Busulfan results in increased phosphorylation of EIF2S1 protein 4-phenylbutyric acid inhibits the reaction [Busulfan results in increased phosphorylation of EIF2S1 protein]
CTD
PMID:35533795
NCBI chr 6:103,405,880...103,430,549
Ensembl chr 6:97,672,766...97,706,225
G
Faslg
Fas ligand
decreases expression
ISO
Busulfan results in decreased expression of FASL mRNA
CTD
PMID:15388331
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:74,154,954...74,162,215
G
Fgf8
fibroblast growth factor 8
decreases expression
EXP
Busulfan results in decreased expression of FGF8 mRNA
CTD
PMID:15786497
NCBI chr 1:254,533,504...254,539,605
Ensembl chr 1:244,584,652...244,590,359
G
Fshb
follicle stimulating hormone subunit beta
decreases expression
ISO
Busulfan results in decreased expression of FSHB protein
CTD
PMID:38123000
NCBI chr 3:114,003,262...114,007,072
Ensembl chr 3:93,548,560...93,552,370
G
Fth1
ferritin heavy chain 1
multiple interactions decreases expression
ISO
3-methyladenine inhibits the reaction [Busulfan results in decreased expression of FTH1 protein]
CTD
PMID:38220133
NCBI chr 1:216,052,037...216,054,325
Ensembl chr 1:206,627,103...206,725,424
G
Gdnf
glial cell derived neurotrophic factor
affects expression increases expression
ISO
Busulfan affects the expression of GDNF mRNA Busulfan results in increased expression of GDNF mRNA
CTD
PMID:20684317 PMID:22082982 PMID:26524245
NCBI chr 2:58,621,327...58,647,242
Ensembl chr 2:56,895,010...56,917,209
G
Gja1
gap junction protein, alpha 1
multiple interactions decreases expression
ISO
4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of GJA1 protein] Busulfan results in decreased expression of GJA1 mRNA; Busulfan results in decreased expression of GJA1 protein
CTD
PMID:35533795
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Gpx4
glutathione peroxidase 4
decreases expression multiple interactions
ISO
Busulfan results in decreased expression of GPX4 mRNA; Busulfan results in decreased expression of GPX4 protein 3-methyladenine inhibits the reaction [Busulfan results in decreased expression of GPX4 protein]; Busulfan results in decreased expression of and results in decreased activity of GPX4 protein; Deferoxamine inhibits the reaction [Busulfan results in decreased expression of GPX4 mRNA]; Deferoxamine inhibits the reaction [Busulfan results in decreased expression of GPX4 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of and results in decreased activity of GPX4 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of GPX4 protein]; sulforaphane inhibits the reaction [Busulfan results in decreased expression of and results in decreased activity of GPX4 protein]
CTD
PMID:32416107 PMID:38220133
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:9,650,185...9,652,982
G
Gsta1
glutathione S-transferase alpha 1
affects response to substance affects metabolic processing affects abundance decreases response to substance multiple interactions
ISO
GSTA1 polymorphism affects the susceptibility to Busulfan GSTA1 gene polymorphism affects the metabolism of Busulfan; GSTA1 protein affects the metabolism of Busulfan GSTA1 gene polymorphism affects the abundance of Busulfan GSTA1 protein results in decreased susceptibility to Busulfan GSTA1 protein affects the metabolism of [Busulfan co-treated with Glutathione]
CTD
PMID:8886613 PMID:10437668 PMID:10570028 PMID:12429583 PMID:20672371 PMID:21135089 PMID:21215809 PMID:21441958 More...
NCBI chr 9:31,199,887...31,216,606
Ensembl chr 9:23,703,477...23,720,121
G
Gstm1
glutathione S-transferase mu 1
multiple interactions affects response to substance affects metabolic processing affects abundance
ISO
[GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Busulfan; [GSTM1 protein co-treated with CYP2C9 protein] results in increased susceptibility to [Busulfan co-treated with Cyclophosphamide] GSTM1 gene polymorphism affects the susceptibility to Busulfan GSTM1 protein affects the metabolism of Busulfan GSTM1 gene polymorphism affects the abundance of Busulfan
CTD
PMID:8886613 PMID:15142875 PMID:19584821 PMID:20672371 PMID:21215809 PMID:28744217 More...
NCBI chr 2:198,338,005...198,346,007
Ensembl chr 2:195,649,845...195,655,411
G
Gstp1
glutathione S-transferase pi 1
affects metabolic processing affects abundance
ISO
GSTP1 protein affects the metabolism of Busulfan GSTP1 gene polymorphism affects the abundance of Busulfan
CTD
PMID:8886613 PMID:20672371
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
multiple interactions
ISO
[GSTM1 gene polymorphism co-treated with GSTT1 gene polymorphism] affects the metabolism of Busulfan
CTD
PMID:21215809
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
H2ax
H2A.X variant histone
increases phosphorylation multiple interactions
ISO
Busulfan results in increased phosphorylation of H2AX protein [Clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased expression of H2AX protein
CTD
PMID:18339423 PMID:20933509
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases expression
ISO
Busulfan results in increased expression of HIF1A mRNA
CTD
PMID:35641671
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions increases expression
ISO
4-phenylbutyric acid inhibits the reaction [Busulfan results in increased expression of HSPA5 protein]
CTD
PMID:35533795
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Inhba
inhibin subunit beta A
multiple interactions increases expression
ISO
bisindolylmaleimide I inhibits the reaction [Busulfan results in increased expression of INHBA mRNA]; bisindolylmaleimide I inhibits the reaction [Busulfan results in increased expression of INHBA protein] Busulfan results in increased expression of INHBA mRNA; Busulfan results in increased expression of INHBA protein
CTD
PMID:12966370 PMID:22286157
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:49,095,920...49,108,982
G
Kit
KIT proto-oncogene receptor tyrosine kinase
decreases expression
ISO
Busulfan results in decreased expression of KIT mRNA
CTD
PMID:15388331
NCBI chr14:32,901,615...32,978,895
Ensembl chr14:32,548,877...32,624,652
G
Lama1
laminin subunit alpha 1
affects expression
ISO
Busulfan affects the expression of LAMA1 mRNA
CTD
PMID:15941629
NCBI chr 9:115,139,548...115,263,620
Ensembl chr 9:107,692,770...107,817,478
G
Lama4
laminin subunit alpha 4
affects expression
ISO
Busulfan affects the expression of LAMA4 mRNA
CTD
PMID:15941629
NCBI chr20:43,946,898...44,087,972
Ensembl chr20:42,392,268...42,533,347
G
Lhb
luteinizing hormone subunit beta
decreases expression
ISO
Busulfan results in decreased expression of LHB protein
CTD
PMID:38123000
NCBI chr 1:105,037,457...105,038,446
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression multiple interactions
ISO
Busulfan results in increased expression of MAP1LC3B protein 3-methyladenine inhibits the reaction [Busulfan results in increased expression of MAP1LC3B protein]
CTD
PMID:38220133
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Mapk1
mitogen activated protein kinase 1
increases activity
ISO
Busulfan results in increased activity of MAPK1 protein
CTD
PMID:16882877
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
increases activity
ISO
Busulfan results in increased activity of MAPK3 protein
CTD
PMID:16882877
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mgst2
microsomal glutathione S-transferase 2
decreases response to substance
ISO
MGST2 protein results in decreased susceptibility to Busulfan
CTD
PMID:15779864
NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:135,693,557...135,715,828
G
Mtf1
metal-regulatory transcription factor 1
decreases expression
ISO
Busulfan results in decreased expression of MTF1 mRNA
CTD
PMID:35641671
NCBI chr 5:142,347,024...142,391,810
Ensembl chr 5:137,062,376...137,107,136
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in decreased expression of MYC protein
CTD
PMID:20933509
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Nanos2
nanos C2HC-type zinc finger 2
decreases expression
ISO
Busulfan results in decreased expression of NANOS2 mRNA; Busulfan results in decreased expression of NANOS2 protein
CTD
PMID:26524245
NCBI chr 1:87,763,716...87,765,176
Ensembl chr 1:78,635,668...78,637,128
G
Nanos3
nanos C2HC-type zinc finger 3
decreases expression
ISO
Busulfan results in decreased expression of NANOS3 mRNA
CTD
PMID:26524245
NCBI chr19:23,978,465...23,988,933
Ensembl chr19:23,985,504...23,988,932
G
Ncoa4
nuclear receptor coactivator 4
increases expression multiple interactions
ISO
Busulfan results in increased expression of NCOA4 protein 3-methyladenine inhibits the reaction [Busulfan results in increased expression of NCOA4 protein]
CTD
PMID:38220133
NCBI chr16:7,395,502...7,415,846
Ensembl chr16:7,366,542...7,409,641 Ensembl chr16:7,366,542...7,409,641
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions increases expression decreases expression
ISO
Deferoxamine inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein]; sulforaphane inhibits the reaction [Busulfan results in decreased expression of NFE2L2 protein] Busulfan results in increased expression of NFE2L2 mRNA
CTD
PMID:32416107 PMID:35641671
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfkb1
nuclear factor kappa B subunit 1
increases expression
ISO
Busulfan results in increased expression of NFKB1 mRNA
CTD
PMID:35641671
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Npm1
nucleophosmin 1
multiple interactions
ISO
NPM1 gene mutant form results in increased susceptibility to [Busulfan co-treated with Idarubicin]
CTD
PMID:20172040
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:17,739,941...17,751,645 Ensembl chr X:17,739,941...17,751,645
G
Ocln
occludin
decreases expression multiple interactions
ISO
Busulfan results in decreased expression of OCLN mRNA; Busulfan results in decreased expression of OCLN protein 4-phenylbutyric acid inhibits the reaction [Busulfan results in decreased expression of OCLN protein]
CTD
PMID:35533795
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:31,657,220...31,764,150
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased cleavage of PARP1 protein; [decitabine co-treated with Busulfan] results in increased cleavage of PARP1 protein; pifithrin inhibits the reaction [[decitabine co-treated with Busulfan] results in increased cleavage of PARP1 protein] Busulfan results in increased cleavage of PARP1 protein
CTD
PMID:18339423 PMID:19732952 PMID:20933509
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Phb1
prohibitin 1
affects expression
ISO
Busulfan affects the expression of PHB1 mRNA
CTD
PMID:15388331
NCBI chr10:81,102,043...81,114,815
Ensembl chr10:80,605,251...80,618,042
G
Pparg
peroxisome proliferator-activated receptor gamma
affects expression
ISO
Busulfan affects the expression of PPARG mRNA
CTD
PMID:35641671
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ptgs2
prostaglandin-endoperoxide synthase 2
increases expression multiple interactions
ISO
Busulfan results in increased expression of PTGS2 mRNA ferrostatin-1 inhibits the reaction [Busulfan results in increased expression of PTGS2 mRNA]
CTD
PMID:12966370 PMID:32416107
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Pus7
pseudouridine synthase 7
increases expression
ISO
Busulfan results in increased expression of PUS7 mRNA
CTD
PMID:34097952
NCBI chr 4:11,360,169...11,401,139
Ensembl chr 4:11,360,188...11,401,172
G
Rad51
RAD51 recombinase
decreases expression
ISO
Busulfan results in decreased expression of RAD51 mRNA
CTD
PMID:15388331
NCBI chr 3:126,554,210...126,578,888
Ensembl chr 3:106,100,381...106,125,035
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation
ISO
Busulfan results in decreased phosphorylation of RB1 protein
CTD
PMID:15388331
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Sat2
spermidine/spermine N1-acetyltransferase family member 2
increases expression
ISO
Busulfan results in increased expression of SAT2 mRNA; Busulfan results in increased expression of SAT2 protein
CTD
PMID:28578006
NCBI chr10:54,839,531...54,841,651
Ensembl chr10:54,340,372...54,343,224
G
Serpinc1
serpin family C member 1
affects expression
ISO
Busulfan affects the expression of SERPINC1 protein
CTD
PMID:15580502
NCBI chr13:75,790,558...75,804,826
Ensembl chr13:73,257,179...73,284,293
G
Serpine1
serpin family E member 1
increases expression multiple interactions
ISO
Busulfan results in increased expression of SERPINE1 mRNA; Busulfan results in increased expression of SERPINE1 protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Busulfan results in increased expression of SERPINE1 mRNA]
CTD
PMID:22286157
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Slc40a1
solute carrier family 40 member 1
multiple interactions decreases expression
ISO
Deferoxamine inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]; sulforaphane inhibits the reaction [Busulfan results in decreased expression of SLC40A1 protein]
CTD
PMID:32416107
NCBI chr 9:55,525,457...55,633,463
Ensembl chr 9:48,033,526...48,051,481
G
Slc7a11
solute carrier family 7 member 11
multiple interactions decreases expression
ISO
3-methyladenine inhibits the reaction [Busulfan results in decreased expression of SLC7A11 protein]; Deferoxamine inhibits the reaction [Busulfan results in decreased expression of SLC7A11 protein]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of SLC7A11 mRNA]; ferrostatin-1 inhibits the reaction [Busulfan results in decreased expression of SLC7A11 protein] Busulfan results in decreased expression of SLC7A11 mRNA; Busulfan results in decreased expression of SLC7A11 protein
CTD
PMID:38220133
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Smc1a
structural maintenance of chromosomes 1A
multiple interactions
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of SMC1A protein
CTD
PMID:20933509
NCBI chr X:24,582,732...24,627,462
Ensembl chr X:21,103,282...21,148,056
G
Smc3
structural maintenance of chromosomes 3
multiple interactions
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in increased phosphorylation of SMC3 protein
CTD
PMID:20933509
NCBI chr 1:262,606,731...262,649,832
Ensembl chr 1:252,601,753...252,644,522
G
Sqstm1
sequestosome 1
multiple interactions decreases expression
ISO
3-methyladenine inhibits the reaction [Busulfan results in decreased expression of SQSTM1 protein]
CTD
PMID:38220133
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Stat1
signal transducer and activator of transcription 1
affects expression
ISO
Busulfan affects the expression of STAT1 mRNA
CTD
PMID:35641671
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Stat2
signal transducer and activator of transcription 2
decreases expression
ISO
Busulfan results in decreased expression of STAT2 mRNA
CTD
PMID:35641671
NCBI chr 7:1,287,025...1,302,858
Ensembl chr 7:702,495...718,967
G
Stra8
stimulated by retinoic acid 8
decreases expression
ISO
Busulfan results in decreased expression of STRA8 mRNA
CTD
PMID:15388331
NCBI chr 4:64,568,580...64,591,914
Ensembl chr 4:63,601,604...63,624,771
G
Tf
transferrin
increases expression multiple interactions
ISO
Busulfan results in increased expression of TF mRNA; Busulfan results in increased expression of TF protein 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Busulfan results in increased expression of TF mRNA]
CTD
PMID:12966370 PMID:22286157
NCBI chr 8:112,668,667...112,695,376
Ensembl chr 8:103,767,995...103,816,511
G
Tfpi
tissue factor pathway inhibitor
decreases expression
ISO
Busulfan results in decreased expression of TFPI mRNA
CTD
PMID:22286157
NCBI chr 3:89,939,862...89,989,253
Ensembl chr 3:69,533,156...69,576,880
G
Tfrc
transferrin receptor
multiple interactions decreases expression
ISO
Deferoxamine promotes the reaction [Busulfan results in decreased expression of TFRC protein]
CTD
PMID:32416107
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:68,163,413...68,185,257
G
Tgfb1
transforming growth factor, beta 1
increases expression multiple interactions
ISO
Busulfan results in increased expression of TGFB1 mRNA pirfenidone inhibits the reaction [Busulfan results in increased expression of TGFB1 mRNA]
CTD
PMID:22286157 PMID:37597760
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Thbs1
thrombospondin 1
increases expression
ISO
Busulfan results in increased expression of THBS1 mRNA
CTD
PMID:22286157
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440
G
Timp1
TIMP metallopeptidase inhibitor 1
increases expression
ISO
Busulfan results in increased expression of TIMP1 mRNA
CTD
PMID:37597760
NCBI chr X:3,766,509...3,772,578
Ensembl chr X:1,212,972...1,217,664
G
Tnf
tumor necrosis factor
increases expression
ISO
Busulfan results in increased expression of TNF mRNA
CTD
PMID:22286157
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
multiple interactions increases expression
ISO
Busulfan affects the phosphorylation of and affects the activity of TP53 protein Busulfan results in increased expression of TP53 mRNA
CTD
PMID:16882877 PMID:35641671
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Txnrd1
thioredoxin reductase 1
decreases activity
EXP
Busulfan results in decreased activity of TXNRD1 protein
CTD
PMID:16085187
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Xbp1
X-box binding protein 1
affects expression
ISO
Busulfan affects the expression of XBP1 mRNA
CTD
PMID:35641671
NCBI chr14:84,604,623...84,609,707
Ensembl chr14:80,390,643...80,395,693
G
Xiap
X-linked inhibitor of apoptosis
multiple interactions
ISO
[clofarabine co-treated with fludarabine co-treated with Busulfan] results in decreased expression of XIAP protein
CTD
PMID:20933509
NCBI chr X:125,756,107...125,803,979
Ensembl chr X:120,897,907...120,934,700
G
Zbtb16
zinc finger and BTB domain containing 16
increases expression
ISO
Busulfan results in increased expression of ZBTB16 mRNA
CTD
PMID:26524245
NCBI chr 8:57,885,886...58,073,507
Ensembl chr 8:48,994,566...49,177,011
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
EXP
Diflubenzuron results in increased expression of CYP1A1 protein
CTD
PMID:8812189
NCBI chr 8:66,991,940...66,998,014
Ensembl chr 8:58,096,077...58,102,125
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects binding
ISO
Diflubenzuron binds to CYP1A2 protein
CTD
PMID:32278787
NCBI chr 8:66,971,261...66,978,149
Ensembl chr 8:58,075,367...58,082,312
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
affects binding
ISO
Diflubenzuron binds to CYP3A4 protein
CTD
PMID:32278787
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:9,015,383...9,285,008
G
Cyp3a23-3a1
cytochrome P450, family 3, subfamily a, polypeptide 23-polypeptide 1
increases expression
EXP
Diflubenzuron results in increased expression of CYP3A23-3A1 protein
CTD
PMID:8812189
NCBI chr12:14,369,950...14,398,803
Ensembl chr12:9,254,475...9,285,030 Ensembl chr12:9,254,475...9,285,030
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
increases activity
ISO
Diflubenzuron results in increased activity of NR1I2 protein
CTD
PMID:16565514
NCBI chr11:75,965,717...76,006,733
Ensembl chr11:62,460,213...62,496,658
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Cyp2a1
cytochrome P450, family 2, subfamily a, polypeptide 1
increases metabolic processing multiple interactions
ISO
CYP2A13 protein results in increased metabolism of Hempa CYP2A13 gene polymorphism inhibits the reaction [CYP2A13 protein results in increased metabolism of Hempa]
CTD
PMID:18669584
NCBI chr 1:91,359,278...91,372,554
Ensembl chr 1:82,231,611...82,244,887
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all